Bulk Manufacturer of Controlled Substances Application: Synthcon, LLC, 10464-10466 [2020-03616]
Download as PDF
<![CDATA[
10464
Federal Register / Vol. 85, No. 36 / Monday, February 24, 2020 / Notices
Marsh Blanton, M.D., 43 FR 27,616,
27,617 (1978).
This rule derives from the text of two
provisions of the CSA. First, Congress
defined the term ‘‘practitioner’’ to mean
‘‘a physician . . . or other person
licensed, registered, or otherwise
permitted, by . . . the jurisdiction in
which he practices . . . , to distribute,
dispense, . . . [or] administer . . . a
controlled substance in the course of
professional practice.’’ 21 U.S.C.
802(21). Second, in setting the
requirements for obtaining a
practitioner’s registration, Congress
directed that ‘‘[t]he Attorney General
shall register practitioners . . . if the
applicant is authorized to dispense . . .
controlled substances under the laws of
the State in which he practices.’’ 21
U.S.C. 823(f). Because Congress has
clearly mandated that a practitioner
possess state authority in order to be
deemed a practitioner under the CSA,
the DEA has held repeatedly that
revocation of a practitioner’s registration
is the appropriate sanction whenever he
is no longer authorized to dispense
controlled substances under the laws of
the state in which he practices. See, e.g.,
James L. Hooper, 76 FR at 71,371–72;
Sheran Arden Yeates, M.D., 71 FR
39,130, 39,131 (2006); Dominick A.
Ricci, M.D., 58 FR 51,104, 51,105 (1993);
Bobby Watts, M.D., 53 FR 11,919, 11,920
(1988); Frederick Marsh Blanton, 43 FR
at 27,617.
According to California statute, ‘‘[n]o
person other than a physician . . . shall
write or issue a prescription.’’ Cal.
Health & Safety Code § 11150 (Westlaw
2019). Further, ‘‘physician,’’ as defined
by California statute, is a person who is
‘‘licensed to practice’’ in California. Id.
§ 11024.
Here, the undisputed evidence in the
record is that Registrant currently lacks
authority to practice medicine in
California. As already discussed, a
physician must be a licensed
practitioner to dispense a controlled
substance in California. Thus, because
Registrant lacks authority to practice
medicine in California and, therefore, is
not authorized to handle controlled
substances in California, Registrant is
not eligible to maintain a DEA
registration. Accordingly, I will order
that Registrant’s DEA registration be
revoked.
Order
Pursuant to 28 CFR 0.100(b) and the
authority vested in me by 21 U.S.C.
824(a), I hereby revoke DEA Certificate
of Registration No. BD9798818 issued to
Jaime C. David, M.D. This Order is
effective March 25, 2020.
Dated: January 31, 2020.
Uttam Dhillon,
Acting Administrator.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–584]
Bulk Manufacturer of Controlled
Substances Application: Synthcon,
LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 24, 2020.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on December 9, 2019,
Synthcon, LLC, 770 Wooten Road, Suite
101, Colorado Springs, Colorado 80915–
3538 applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
SUPPLEMENTARY INFORMATION:
[FR Doc. 2020–03626 Filed 2–21–20; 8:45 am]
BILLING CODE 4410–09–P
lotter on DSKBCFDHB2PROD with NOTICES
Controlled substance
Drug code
Amphetamine ...................................................................................................................................................................
Methamphetamine ...........................................................................................................................................................
3-Fluoro-N-methylcathinone (3-FMC) ..............................................................................................................................
Cathinone ........................................................................................................................................................................
Methcathinone .................................................................................................................................................................
4-Fluoro-N-methylcathinone (4-FMC) ..............................................................................................................................
Pentedrone (a-methylaminovalerophenone) ...................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ....................................................................................................................
4-Methyl-N-ethylcathinone (4-MEC) ................................................................................................................................
Naphyrone .......................................................................................................................................................................
N-Ethylamphetamine .......................................................................................................................................................
N,N-Dimethylamphetamine ..............................................................................................................................................
Aminorex ..........................................................................................................................................................................
4-Methylaminorex (cis isomer) ........................................................................................................................................
Gamma Hydroxybutyric Acid ...........................................................................................................................................
Methaqualone ..................................................................................................................................................................
Mecloqualone ..................................................................................................................................................................
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ...................................................................................................
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ..................................
JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ..............................................................................
JWH-073 (1-Butyl-3-(1-naphthoyl)indole) ........................................................................................................................
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ...........................................................................................
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ......................................................................................................
Alpha-ethyltryptamine ......................................................................................................................................................
Ibogaine ...........................................................................................................................................................................
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) .................................................................
CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ...........................................
Lysergic acid diethylamide ..............................................................................................................................................
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) ................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
Mescaline .........................................................................................................................................................................
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2 ) ............................................................................................
VerDate Sep<11>2014
18:30 Feb 21, 2020
Jkt 250001
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
E:\FR\FM\24FEN1.SGM
24FEN1
1100
1105
1233
1235
1237
1238
1246
1248
1249
1258
1475
1480
1585
1590
2010
2565
2572
6250
7035
7118
7173
7200
7203
7249
7260
7297
7298
7315
7348
7370
7381
7385
Schedule
II
II
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
10465
Federal Register / Vol. 85, No. 36 / Monday, February 24, 2020 / Notices
lotter on DSKBCFDHB2PROD with NOTICES
Controlled substance
Drug code
3,4,5-Trimethoxyamphetamine ........................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine .............................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ..........................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine .............................................................................................................................
2,5-Dimethoxyamphetamine ............................................................................................................................................
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ......................................................................................................
2,5-Dimethoxy-4-ethylamphetamine ................................................................................................................................
3,4-Methylenedioxyamphetamine ....................................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine ..................................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine ..................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine .......................................................................................................................
3,4-Methylenedioxymethamphetamine ............................................................................................................................
4-Methoxyamphetamine ..................................................................................................................................................
5-Methoxy-N-N-dimethyltryptamine .................................................................................................................................
Alpha-methyltryptamine ...................................................................................................................................................
Bufotenine ........................................................................................................................................................................
Diethyltryptamine .............................................................................................................................................................
Dimethyltryptamine ..........................................................................................................................................................
Psilocybin .........................................................................................................................................................................
Psilocyn ...........................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine .............................................................................................................................
N-Ethyl-1-phenylcyclohexylamine ....................................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine ....................................................................................................................................
1-Phenylcyclohexylamine ................................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine ...............................................................................................................................
Phencyclidine ...................................................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine ..............................................................................................................................
N-Ethyl-3-piperidyl benzilate ............................................................................................................................................
N-Methyl-3-piperidyl benzilate .........................................................................................................................................
N-Benzylpiperazine ..........................................................................................................................................................
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) .....................................................................................................
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D) ..................................................................................................
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E ) ....................................................................................................
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) .................................................................................................................
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C-I) ........................................................................................................
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C) ...................................................................................................
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N) .....................................................................................................
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P) ..............................................................................................
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4 ) ....................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) .......................................................................................................................
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B-NBOMe) .....................................................
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe) .....................................................
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I-NBOMe) ..........................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ......................................................................................................
Butylone ...........................................................................................................................................................................
Pentylone .........................................................................................................................................................................
alpha-pyrrolidinopentiophenone (a-PVP) ........................................................................................................................
alpha-pyrrolidinobutiophenone (a-PBP) ..........................................................................................................................
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ....................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) .....................................................................................................................
Phenylacetone .................................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile ................................................................................................................................
Alphaprodine ....................................................................................................................................................................
Anileridine ........................................................................................................................................................................
Cocaine ............................................................................................................................................................................
Etorphine (except HCl) ....................................................................................................................................................
Diphenoxylate ..................................................................................................................................................................
Ecgonine ..........................................................................................................................................................................
Heroin ..............................................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Meperidine intermediate-A ..............................................................................................................................................
Meperidine intermediate-B ..............................................................................................................................................
Meperidine intermediate-C ..............................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..............................................................................................................
Morphine ..........................................................................................................................................................................
Normorphine ....................................................................................................................................................................
Acetorphine ......................................................................................................................................................................
U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ...............................................................
AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) ..................................................................
Acetylmethadol ................................................................................................................................................................
Allylprodine ......................................................................................................................................................................
Alphacetylmethadol except levo-alphacetylmethadol ......................................................................................................
Alphameprodine ...............................................................................................................................................................
VerDate Sep<11>2014
18:30 Feb 21, 2020
Jkt 250001
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
E:\FR\FM\24FEN1.SGM
24FEN1
7390
7391
7392
7395
7396
7398
7399
7400
7401
7402
7404
7405
7411
7431
7432
7433
7434
7435
7437
7438
7439
7455
7458
7460
7470
7471
7473
7482
7484
7493
7498
7508
7509
7517
7518
7519
7521
7524
7532
7535
7536
7537
7538
7540
7541
7542
7545
7546
7694
8333
8501
8603
9010
9020
9041
9056
9170
9180
9200
9220
9230
9232
9233
9234
9273
9300
9313
9319
9547
9551
9601
9602
9603
9604
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
I
II
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
I
II
II
I
II
II
II
II
II
II
II
I
I
I
I
I
I
I
I
10466
Federal Register / Vol. 85, No. 36 / Monday, February 24, 2020 / Notices
Controlled substance
Drug code
Alphamethadol .................................................................................................................................................................
Benzethidine ....................................................................................................................................................................
Betacetylmethadol ...........................................................................................................................................................
Clonitazene ......................................................................................................................................................................
Diampromide ...................................................................................................................................................................
Diethylthiambutene ..........................................................................................................................................................
Dimethylthiambutene .......................................................................................................................................................
Ketobemidone ..................................................................................................................................................................
Levo-alphacetylmethadol .................................................................................................................................................
1-Methyl-4-phenyl-4-propionoxypiperidine ......................................................................................................................
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine ..............................................................................................................
Alfentanil ..........................................................................................................................................................................
Remifentanil .....................................................................................................................................................................
Sufentanil .........................................................................................................................................................................
Carfentanil .......................................................................................................................................................................
Tilidine .............................................................................................................................................................................
Tapentadol .......................................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
Para-Fluorofentanyl .........................................................................................................................................................
3-Methylfentanyl ..............................................................................................................................................................
Alpha-methylfentanyl .......................................................................................................................................................
Acetyl-alpha-methylfentanyl .............................................................................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ...............................................................................
Beta-hydroxyfentanyl .......................................................................................................................................................
Beta-hydroxy-3-methylfentanyl ........................................................................................................................................
Alpha-methylthiofentanyl .................................................................................................................................................
3-Methylthiofentanyl .........................................................................................................................................................
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) .............................................................
Thiofentanyl .....................................................................................................................................................................
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide ..........................................................................
Cyclopropyl Fentanyl .......................................................................................................................................................
Fentanyl related-compounds as defined in 21 CFR 1308.11&h) ...................................................................................
Morrissette Drive, Springfield, Virginia
22152.
The company plans to manufacture
the above-listed controlled substances
as analytical reference standards for
distribution to its customers. No other
activities for these drug codes are
authorized for this registration.
In
accordance with 21 CFR 1301.33(a), this
is notice that on December 18, 2019,
Stepan Company, 100 West Hunter
Avenue, Maywood, New Jersey 07607–
1021 applied to be registered as a bulk
manufacturer of the following basic
class of controlled substances:
SUPPLEMENTARY INFORMATION:
Dated: February 3, 2020.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–03616 Filed 2–21–20; 8:45 am]
BILLING CODE 4410–09–P
Drug
code
Controlled substance
DEPARTMENT OF JUSTICE
Cocaine ........................
Ecgonine .......................
Drug Enforcement Administration
[Docket No. DEA–580]
lotter on DSKBCFDHB2PROD with NOTICES
Dated: February 3, 2020.
William T. McDermott,
Assistant Administrator.
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 24, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
DATES:
VerDate Sep<11>2014
18:30 Feb 21, 2020
Jkt 250001
I
II
II
The company plans to manufacture
the above-listed controlled substances
in bulk for distribution to its customers.
Bulk Manufacturer of Controlled
Substances Application: Stepan
Company
ACTION:
I
9041
9180
Schedule
[FR Doc. 2020–03618 Filed 2–21–20; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
9605
9606
9607
9612
9615
9616
9619
9628
9648
9661
9663
9737
9739
9740
9743
9750
9780
9801
9812
9813
9814
9815
9821
9830
9831
9832
9833
9834
9835
9843
9845
9850
Schedule
I
I
I
I
I
I
I
I
II
I
I
II
II
II
II
I
II
II
I
I
I
I
I
I
I
I
I
I
I
I
I
I
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–586]
Importer of Controlled Substances
Application: Research Triangle
Institute
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before March 25, 2020. Such persons
may also file a written request for a
hearing on the application on or before
March 25, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
DATES:
E:\FR\FM\24FEN1.SGM
24FEN1
]]>Agencies
[Federal Register Volume 85, Number 36 (Monday, February 24, 2020)]
[Notices]
[Pages 10464-10466]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03616]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-584]
Bulk Manufacturer of Controlled Substances Application: Synthcon,
LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before April 24, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on December 9, 2019, Synthcon, LLC, 770 Wooten Road,
Suite 101, Colorado Springs, Colorado 80915-3538 applied to be
registered as a bulk manufacturer of the following basic classes of
controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Amphetamine........................ 1100 II
Methamphetamine.................... 1105 II
3-Fluoro-N-methylcathinone (3-FMC). 1233 I
Cathinone.......................... 1235 I
Methcathinone...................... 1237 I
4-Fluoro-N-methylcathinone (4-FMC). 1238 I
Pentedrone ([alpha]- 1246 I
methylaminovalerophenone).
Mephedrone (4-Methyl-N- 1248 I
methylcathinone).
4-Methyl-N-ethylcathinone (4-MEC).. 1249 I
Naphyrone.......................... 1258 I
N-Ethylamphetamine................. 1475 I
N,N-Dimethylamphetamine............ 1480 I
Aminorex........................... 1585 I
4-Methylaminorex (cis isomer)...... 1590 I
Gamma Hydroxybutyric Acid.......... 2010 I
Methaqualone....................... 2565 I
Mecloqualone....................... 2572 I
JWH-250 (1-Pentyl-3-(2- 6250 I
methoxyphenylacetyl) indole).
ADB-PINACA (N-(1-amino-3,3-dimethyl- 7035 I
1-oxobutan-2-yl)-1-pentyl-1H-
indazole-3-carboxamide).
JWH-018 (also known as AM678) (1- 7118 I
Pentyl-3-(1-naphthoyl)indole).
JWH-073 (1-Butyl-3-(1- 7173 I
naphthoyl)indole).
JWH-200 (1-[2-(4-Morpholinyl)ethyl]- 7200 I
3-(1-naphthoyl)indole).
JWH-203 (1-Pentyl-3-(2- 7203 I
chlorophenylacetyl) indole).
Alpha-ethyltryptamine.............. 7249 I
Ibogaine........................... 7260 I
CP-47,497 (5-(1,1-Dimethylheptyl)-2- 7297 I
[(1R,3S)-3-hydroxycyclohexyl-
phenol).
CP-47,497 C8 Homologue (5-(1,1- 7298 I
Dimethyloctyl)-2-[(1R,3S)3-
hydroxycyclohexyl-phenol).
Lysergic acid diethylamide......... 7315 I
2,5-Dimethoxy-4-(n)- 7348 I
propylthiophenethylamine (2C-T-7).
Tetrahydrocannabinols.............. 7370 I
Mescaline.......................... 7381 I
2-(4-Ethylthio-2,5-dimethoxyphenyl) 7385 I
ethanamine (2C-T-2 ).
[[Page 10465]]
3,4,5-Trimethoxyamphetamine........ 7390 I
4-Bromo-2,5-dimethoxyamphetamine... 7391 I
4-Bromo-2,5-dimethoxyphenethylamine 7392 I
4-Methyl-2,5-dimethoxyamphetamine.. 7395 I
2,5-Dimethoxyamphetamine........... 7396 I
JWH-398 (1-Pentyl-3-(4-chloro-1- 7398 I
naphthoyl) indole).
2,5-Dimethoxy-4-ethylamphetamine... 7399 I
3,4-Methylenedioxyamphetamine...... 7400 I
5-Methoxy-3,4- 7401 I
methylenedioxyamphetamine.
N-Hydroxy-3,4- 7402 I
methylenedioxyamphetamine.
3,4-Methylenedioxy-N- 7404 I
ethylamphetamine.
3,4-Methylenedioxymethamphetamine.. 7405 I
4-Methoxyamphetamine............... 7411 I
5-Methoxy-N-N-dimethyltryptamine... 7431 I
Alpha-methyltryptamine............. 7432 I
Bufotenine......................... 7433 I
Diethyltryptamine.................. 7434 I
Dimethyltryptamine................. 7435 I
Psilocybin......................... 7437 I
Psilocyn........................... 7438 I
5-Methoxy-N,N-diisopropyltryptamine 7439 I
N-Ethyl-1-phenylcyclohexylamine.... 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine.. 7458 I
1-Phenylcyclohexylamine............ 7460 II
1-[1-(2- 7470 I
Thienyl)cyclohexyl]piperidine.
Phencyclidine...................... 7471 II
1-[1-(2- 7473 I
Thienyl)cyclohexyl]pyrrolidine.
N-Ethyl-3-piperidyl benzilate...... 7482 I
N-Methyl-3-piperidyl benzilate..... 7484 I
N-Benzylpiperazine................. 7493 I
4-Methyl- 7498 I
alphapyrrolidinopropiophenone (4-
MePPP).
2-(2,5-Dimethoxy-4-methylphenyl) 7508 I
ethanamine (2C-D).
2-(2,5-Dimethoxy-4-ethylphenyl) 7509 I
ethanamine (2C-E ).
2-(2,5-Dimethoxyphenyl) ethanamine 7517 I
(2C-H).
2-(4-iodo-2,5-dimethoxyphenyl) 7518 I
ethanamine (2C-I).
2-(4-Chloro-2,5-dimethoxyphenyl) 7519 I
ethanamine (2C-C).
2-(2,5-Dimethoxy-4-nitro-phenyl) 7521 I
ethanamine (2C-N).
2-(2,5-Dimethoxy-4-(n)- 7524 I
propylphenyl) ethanamine (2C-P).
2-(4-Isopropylthio)-2,5- 7532 I
dimethoxyphenyl) ethanamine (2C-T-
4 ).
MDPV (3,4- 7535 I
Methylenedioxypyrovalerone).
2-(4-bromo-2,5-dimethoxyphenyl)-N- 7536 I
(2-methoxybenzyl) ethanamine (25B-
NBOMe).
2-(4-chloro-2,5-dimethoxyphenyl)-N- 7537 I
(2-methoxybenzyl) ethanamine (25C-
NBOMe).
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2- 7538 I
methoxybenzyl) ethanamine (25I-
NBOMe).
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Butylone........................... 7541 I
Pentylone.......................... 7542 I
alpha-pyrrolidinopentiophenone 7545 I
([alpha]-PVP).
alpha-pyrrolidinobutiophenone 7546 I
([alpha]-PBP).
AM-694 (1-(5-Fluoropentyl)-3-(2- 7694 I
iodobenzoyl) indole).
4-Anilino-N-phenethyl-4-piperidine 8333 II
(ANPP).
Phenylacetone...................... 8501 II
1-Piperidinocyclohexanecarbonitrile 8603 II
Alphaprodine....................... 9010 II
Anileridine........................ 9020 II
Cocaine............................ 9041 II
Etorphine (except HCl)............. 9056 I
Diphenoxylate...................... 9170 II
Ecgonine........................... 9180 II
Heroin............................. 9200 I
Levorphanol........................ 9220 II
Meperidine......................... 9230 II
Meperidine intermediate-A.......... 9232 II
Meperidine intermediate-B.......... 9233 II
Meperidine intermediate-C.......... 9234 II
Dextropropoxyphene, bulk (non- 9273 II
dosage forms).
Morphine........................... 9300 II
Normorphine........................ 9313 I
Acetorphine........................ 9319 I
U-47700 (3,4-dichloro-N-[2- 9547 I
(dimethylamino)cyclohexyl]-N-
methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1- 9551 I
dimethylamino)cyclohexylmethyl]ben
zamide)).
Acetylmethadol..................... 9601 I
Allylprodine....................... 9602 I
Alphacetylmethadol except levo- 9603 I
alphacetylmethadol.
Alphameprodine..................... 9604 I
[[Page 10466]]
Alphamethadol...................... 9605 I
Benzethidine....................... 9606 I
Betacetylmethadol.................. 9607 I
Clonitazene........................ 9612 I
Diampromide........................ 9615 I
Diethylthiambutene................. 9616 I
Dimethylthiambutene................ 9619 I
Ketobemidone....................... 9628 I
Levo-alphacetylmethadol............ 9648 II
1-Methyl-4-phenyl-4- 9661 I
propionoxypiperidine.
1-(2-Phenylethyl)-4-phenyl-4- 9663 I
acetoxypiperidine.
Alfentanil......................... 9737 II
Remifentanil....................... 9739 II
Sufentanil......................... 9740 II
Carfentanil........................ 9743 II
Tilidine........................... 9750 I
Tapentadol......................... 9780 II
Fentanyl........................... 9801 II
Para-Fluorofentanyl................ 9812 I
3-Methylfentanyl................... 9813 I
Alpha-methylfentanyl............... 9814 I
Acetyl-alpha-methylfentanyl........ 9815 I
Acetyl Fentanyl (N-(1- 9821 I
phenethylpiperidin-4-yl)-N-
phenylacetamide).
Beta-hydroxyfentanyl............... 9830 I
Beta-hydroxy-3-methylfentanyl...... 9831 I
Alpha-methylthiofentanyl........... 9832 I
3-Methylthiofentanyl............... 9833 I
Furanyl fentanyl (N-(1- 9834 I
phenethylpiperidin-4-yl)-N-
phenylfuran-2-carboxamide).
Thiofentanyl....................... 9835 I
N-(1-phenethylpiperidin-4-yl)-N- 9843 I
phenyltetrahydrofuran-2-
carboxamide.
Cyclopropyl Fentanyl............... 9845 I
Fentanyl related-compounds as 9850 I
defined in 21 CFR 1308.11&h).
------------------------------------------------------------------------
The company plans to manufacture the above-listed controlled
substances as analytical reference standards for distribution to its
customers. No other activities for these drug codes are authorized for
this registration.
Dated: February 3, 2020.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-03616 Filed 2-21-20; 8:45 am]
BILLING CODE 4410-09-P
